Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia
Clinical trial NCT07726576 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07726576
- Sponsor
- University Hospital, Bordeaux
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.